DILATATION INTRAHEPATIC DUCT CONGENITAL

This adverse event was reported 10 times

DILATATION INTRAHEPATIC DUCT CONGENITAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALPHA1-PROTEINASE INHIBITOR (HUMAN) 1 0.0005
1 NELFINAVIR MESYLATE 1 0.0005
2 ZIDOVUDINE 1 0.0001
3 MYCOPHENILIC ACID 1 0.0000
4 CEPHALEXIN 1 0.0000
5 MYCOPHENOLIC ACID 1 0.0000
6 CYCLOSPORINE 2 0.0000
7 SULFAMETHOXAZOLE AND TRIMETHOPRIM 1 0.0000
8 HYDROCORTISONE 1 0.0000
9 RAMIPRIL 1 0.0000
See all drugs enriched for association with DILATATION INTRAHEPATIC DUCT CONGENITAL